Abiopharma

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant

Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Gold Resource Corporation Announces Special Shareholder Meeting to Vote on Strategic Merger With Goldgroup Mining

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

General Announcement: Change of Name of Wholly-Owned Subsidiaries

ABM Reports Fiscal Second Quarter 2026 Results and Reaffirms Fiscal 2026 Adjusted EPS Outlook

General Announcement: Reporting Share Repurchase form for Financial Management Purposes No.2

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Change in Interest of Substantial Shareholder